Author:
Hoshina Sari,Miura Junnosuke,Sugizawa Eri,Shimura Kanako,Uchigata Yasuko
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference16 articles.
1. Kobayashi T, Tamaemoto K, Nakanishi K, Kato N, Okubo M, Kajio H, Sugimoto T, Murase T, Kosaka K. Immunogenetic and clinical characterization of slowly progressive IDDM. Diabetes Care. 1993;16:780–8.
2. Tuomi T, Carlsson A, Li H, Isomaa B, Miettinen A, Nilsson A, Nissén M, Ehrnström BO, Forsén B, Snickars B, Lahti K, Forsblom C, Saloranta C, Taskinen MR, Groop LC. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes. 1999;48:150–7.
3. Yamada K, Yuan X, Inada C, Hayashi H, Koyama K, Ichikawa F, Eisenbarth GS, Nonaka K. Combined measurements of GAD65 and ICA512 antibodies in acute onset and slowly progressive IDDM. Diabetes Res Clin Pract. 1997;35:91–8.
4. Takino H, Yamasaki H, Abiru N, Sera Y, Abe T, Kawasaki E, Yamaguchi Y, Eguchi K, Kanazawa Y, Nagataki S. Antibodies to GAD in Japanese patients classified as type 2 diabetes at diagnosis. High titer of GAD Ab is a predictive marker for early insulin treatment-report of west Japan (Kyushu, Yamaguchi, Osaka) study for GAD Ab (+) diabetes. Diabet Med. 2002;19:730–4.
5. Matsuba I, Tsuruoka A, Kawasaki E, Toyoda T, Isshiki G, Nagataki S, Ikeda Y. Measurement of GAD antibody in IDDM, NIDDM and non-diabetic controls. Multicent Study Pract. 1994;11:274–8 (in Japanese).
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献